Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
79 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH from Brussel, company number BE0766541015, closed financial year 2025 with a result of € 4,584 after tax. For that financial year DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH recorded a gross margin of € 75,556 and equity of € 0. Compared with financial year 2024, the result moved from € -499,647 to € 4,584. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ 0
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,584
▲ still € 499,647 loss in 2024
Profit after tax over the fiscal year.
€ 3.6 million
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 4,584 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 72,284
▼ 82% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,369
▼ 23% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 356,959 | € 160,531 | € -420,904 | € 75,556 | ▲ € 496,460 |
| Profit after taxes | € 356,055 | € 133,642 | € -499,647 | € 4,584 | ▲ € 504,231 |
| Equity | € 369,853 | € 503,495 | € 0 | € 0 | |
| Total debts | € 9,151 | € 6,934,282 | € 8,015,782 | € 6,522,338 | ▼ 19% |
| Cash | € 70,575 | € 6,536,926 | € 4,621,535 | € 3,627,187 | ▼ 22% |
| Retained profit | € 369,853 | € 503,495 | € 0 | € 0 | |
| Dividend | € 0 | € 0 | € 3,848 | € 4,584 | ▲ 19% |
| Balance sheet total | € 379,004 | € 7,437,777 | € 8,015,782 | € 6,522,338 | ▼ 19% |
By gross margin, DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH ranks 98th of 228 companies with main activity “Ontwerpen van computerprogramma’s” in Brussel that publish figures (fiscal year 2025).
Key figures of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH?
What happened at DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Cathy Mary ENRIGHT stepped down as director. NBB
- Aslaug HELLAND stepped down as director. NBB
- Alessandro SGAMBATO stepped down as director. NBB
- Xose Maria FERNANDEZ stepped down as director. NBB
- Amaury MARTIN stepped down as director. NBB
- Giovanni TONON stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 4,584. Source: NBB ↗
- Cathy Mary ENRIGHT became a director. NBB
In short
From € 356,055 profit in 2022 to € 4,584 profit in 2025.
Best year ever: 2022, with € 356,055 profit.
Paid out € 8,432 in dividends to the owners in total.
Management
Directors
According to the 2025 annual accounts
Cathy Mary ENRIGHT
Trésorier
since 2025 · until 2028
Alessandro SGAMBATO
Director
since 2024 · until 2027
Xose Maria FERNANDEZ
Director
since 2024 · until 2027
Aslaug HELLAND
Director
since 2024 · until 2028
Amaury MARTIN
Director
since 2024 · until 2027
Giovanni TONON
Chairman of the board
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Egmontstraat 11
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 79 companies are registered at this address.
All companies at this address →Fédération Royale d' Associations Belges d'Ingénieurs
Conférence Olivaint de Belgique-Olivaint Genootschap van Belgie
Ligue européenne de Coopération économique
STICHTING HOOVER VOOR DE ONTWIKKELING VAN DE KATHOLIEKE UNIVERSITEIT TE LEUVEN (K.U.Leuven) EN VAN DE UNIVERSITE CATHOLIQUE DE LOUVAIN (U.C.L.)
Fondation Nationale du Cancer
+74 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Ontwerpen van computerprogramma’s), 294 active companies in Brussel, largest first.
€ 161.7 million revenue · 2025
BNP PARIBAS PARTNERS FOR INNOVATION BELGIUM
€ 73.5 million revenue · 2025
€ 68.5 million revenue · 2025
€ 64.3 million revenue · 2025
€ 50.3 million revenue · 2025
TELEKOM HELLENIC BUSINESS SOLUTIONS
€ 41.5 million revenue · 2024
Details
- Company number
- 0766.541.015
- VAT number
- BE 0766.541.015
- Registered office
- Egmontstraat 11, 1000 Brussel
- Names & denominations
- DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH
- Enterprise type
- Rechtspersoon
- Legal form
- Europees economisch samenwerkingsverband
- Legal situation
- Normale toestand
- Start date
- 9 April 2021
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied